Thinking of joining a study?

Register your interest

NCT05369325 | Completed | Total Joint Arthroplasty


Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty
Sponsor:

Mayo Clinic

Information provided by (Responsible Party):

Matthew P. Abdel, M.D.

Brief Summary:

This research is being done to better understand the accuracy of noninvasive hemoglobin tests on patients that recently underwent total joint arthroplasty.

Condition or disease

Total Joint Arthroplasty

Study Type : Observational
Estimated Enrollment : 200 participants
Official Title: Accuracy of Non-invasive Hemoglobin Monitoring in Patients Undergoing Outpatient Total Joint Arthroplasty
Actual Study Start Date : June 15, 2022
Estimated Primary Completion Date : July 1, 2023
Estimated Study Completion Date : July 1, 2023

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Accepts Healthy Volunteers
Criteria
Inclusion Criteria
  • Adult patients age ≥ 18.
  • Undergoing either primary total knee or total hip arthroplasty for a primary underlying diagnosis of osteoarthritis.
Exclusion Criteria
  • - Individuals < 18 years of age.

Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty

Location Details


Please Choose a site



Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, Minnesota

Mayo Clinic Rochester

Rochester, Minnesota, United States, 55905

Loading...